MB Pharm Rise Baltic Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 2,291 |
| - |
| -14,289 |
| -14,289 |
| - |
| -327.02 |
| -623.70 |
| -14,288 |
| 17,669 |
| 0 |
| 3,381 |
| 2025 |
|---|
| 6,714 |
| - |
| -5,032 |
| -5,032 |
| - |
| 59.92 |
| -74.95 |
| -19,318 |
| 26,080 |
| 584 |
| 6,178 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 6,714 |
| - |
| -5,032 |
| -5,032 |
| - |
| 59.92 |
| -74.95 |
| -19,318 |
| 26,080 |
| 584 |
| 6,178 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
6,714 €193 % *
Sales per employee (€)
-Profit before tax (€)
-5,032 €65 % *
Net Profit (€)
-5,032 €65 % *
Profit per employee (€)
-Total profitability (%)
59.92 %118.32 % *
Net profitability (%)
-74.95 %87.98 % *
Equity (€)
-19,318 €-35 % *
Amounts Payable And Liabilities (€)
26,080 €48 % *
Non-current Assets (€)
584 €- *
CurrentAssets (€)
6,178 €83 % *
